Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA.

Sagiv, Eyal; Starr, Alex; Rozovski, Uri; Khosravi, Rami; Altevogt, Peter; Wang, Timothy; Arber, Nadir

Sagiv, Eyal; Starr, Alex; Rozovski, Uri; Khosravi, Rami; Altevogt, Peter; Wang, Timothy; Arber, Nadir.

Affiliation

Sagiv E; The Integrated Cancer Prevention Center, Tel Aviv Medical Center, Tel Aviv, Israel.

Cancer Res ; 68(8): 2803-12, 2008 Apr 15.

Article in En | MEDLINE | ID: mdl-18413748

Subject(s)

Antibodies, Monoclonal/therapeutic use; CD24 Antigen/genetics; Colorectal Neoplasms/drug therapy; Pancreatic Neoplasms/drug therapy; RNA, Small Interfering/therapeutic use; CD24 Antigen/immunology; Cell Division; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms/pathology; Humans; Pancreatic Neoplasms/pathology; Plasmids; Reverse Transcriptase Polymerase Chain Reaction

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Colorectal Neoplasms / RNA, Small Interfering / CD24 Antigen / Antibodies, Monoclonal Limits: Humans Language: En Year: 2008 Type: Article

Fulltext

XML

PubMed Links

Search on Google